Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bioblast Pharma Ltd (NASDAQ:ORPN)

1.88
Delayed Data
As of 11:09am ET
 +0.0706 / +3.90%
Today’s Change
1.49
Today|||52-Week Range
7.75
-63.83%
Year-to-Date
No recent news for Bioblast Pharma Ltd.

Today’s Trading

Previous close1.81
Today’s open1.91
Day’s range1.88 - 1.97
Volume1,010
Average volume (3 months)55,985
Market cap$6.0M
Data as of 11:09am ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+6.48%
Earnings growth (this year)+9.90%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.68

Competitors

 Today’s
change
Today’s
% change
TENXTenax Therapeutics I...+0.01+2.40%
CLSNCelsion Corp-0.05-1.79%
IGCIndia Globalization ...-0.01-1.69%
SNGXSoligenix Inc+0.05+2.62%
Data as of 11:22am ET, 12/15/2017

Financials

Next reporting dateFebruary 23, 2018
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Fredric D. Price
Chief Medical Officer &
VP-Research
Warren W. Wasiewski
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts